Compare Saxagliptin vs Sitagliptin head-to-head with other drugs for uses, ratings, cost, side effects and interactions.

Januvia (sitagliptin) and Onglyza (saxagliptin) are both medications used to treat Type 2 diabetes and belong to the same drug class, dipeptidyl peptidase-4 (DPP-4) inhibitors. Januvia is a …

While both medications are effective in managing diabetes, saxagliptin has a longer half-life and may be taken once daily, whereas sitagliptin is typically taken twice daily. Additionally, …

Sitagliptin 100 mg monotherapy and saxagliptin 5 mg resulted in greater HbA1c reduction compared to placebo [weighted mean difference (WMD) -0.82%, 95% CI -0.95 to -0.70 and …

Patients aged 18 years and older currently being prescribed alogliptin (Vipidia®), linagliptin (Trajenta®), saxagliptin (Onglyza®), vildagliptin (Galvus®) and branded sitagliptin (Januvia®) …

2018年12月3日 · Inhibits dipeptidyl peptidase IV (DPP-IV) enzyme, which prolongs the action of the incretin hormones, glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic …

2021年7月28日 · Linagliptin and sitagliptin are the two most common DPP4 inhibitors that I have seen used in my practice with an occasional saxagliptin mixed in. Saxagliptin and alogliptin are …

2011年11月19日 · Sitagliptin 100 mg monotherapy and saxagliptin 5 mg resulted in greater HbA1c reduction compared to placebo [weighted mean difference (WMD) −0.82%, 95% CI …

2014年5月31日 · However, for FBG control, saxagliptin demonstrated superiority to sitagliptin, while, inferiority to vildagliptin. The three gliptins showed almost similar glycemic control and …

2013年7月21日 · Yes, on DPP-4: The standard dose is 5 mg for saxagliptin and 100 mg for sitagliptin for inhibition of the enzyme dpp-4. The two molecules are very different and might …